Definitive Healthcare Stock Price, News & Analysis (NASDAQ:DH)

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DH shares.
View DH analyst ratings or view top-rated stocks.

8 brokers have issued 12-month target prices for Definitive Healthcare's stock. Their DH share price targets range from $9.50 to $15.00. On average, they anticipate the company's share price to reach $11.94 in the next twelve months. This suggests a possible upside of 41.8% from the stock's current price.
View analysts price targets for DH or view top-rated stocks among Wall Street analysts.

Definitive Healthcare's stock was trading at $10.99 at the beginning of 2023. Since then, DH stock has decreased by 23.4% and is now trading at $8.42.
View the best growth stocks for 2023 here.

Definitive Healthcare saw a increase in short interest in November. As of November 15th, there was short interest totaling 6,370,000 shares, an increase of 25.6% from the October 31st total of 5,070,000 shares. Based on an average daily trading volume, of 840,700 shares, the days-to-cover ratio is currently 7.6 days. Currently, 13.8% of the shares of the stock are short sold.
View Definitive Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our DH earnings forecast.

Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Thursday, November, 2nd. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.02 by $0.01. The company had revenue of $65.33 million for the quarter, compared to the consensus estimate of $63.60 million. Definitive Healthcare had a negative net margin of 73.75% and a positive trailing twelve-month return on equity of 0.50%.

ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG), Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

Definitive Healthcare updated its fourth quarter earnings guidance on Thursday, November, 2nd. The company provided EPS guidance of $0.06-0.08 for the period, compared to the consensus estimate of $0.03. The company issued revenue guidance of $65.5-66.5 million, compared to the consensus revenue estimate of $66.90 million.

(DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

Definitive Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (4.36%), Conestoga Capital Advisors LLC (4.35%), Brown Advisory Inc. (3.50%), Riverbridge Partners LLC (2.30%), Fred Alger Management LLC (2.20%) and Clearbridge Investments LLC (1.94%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends.

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.